Ery-ped
Product Images NDC 80005-155

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ery-ped (NDC 80005-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carnegie Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (400 mg per 5 mL Bottle Label)

EryPed 400 oral suspension label for erythromycin ethylsuccinate, USP, showing 400 mg per 5 mL concentration when reconstituted. The label includes NDC 80005-155-18, instructions for mixing and storage, dosage details, and manufacturer Carnegie Pharmaceuticals LLC, Delran, NJ. The product is for prescription use only.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

Chemical structure diagram of the active ingredient in Ery-Ped, showing its molecular arrangement with labeled atoms and bonds, highlighting functional groups and stereochemistry details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.